Kraft Heinz to remove all artificial colors from its U.S. products by 2027, reflecting a trend toward cleaner food labeling.
Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
Trump's call for Tehran evacuation sparks market volatility and fears of wider Middle East conflict, as Iran's nuclear ambitions and military escalation add to the unsettled trading environment.
Kraft Heinz to remove all artificial colors from its U.S. products by 2027, reflecting a trend toward cleaner food labeling.
Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
Trump's call for Tehran evacuation sparks market volatility and fears of wider Middle East conflict, as Iran's nuclear ambitions and military escalation add to the unsettled trading environment.